Healthcare provider profile · identity verified

Jonathan Grant Harrell, MD

Internal Medicine · GAINESVILLE, FL · NPI 1831417799

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	476	147
Amlodipine Besylate	Amlodipine Besylate	303	99
Lisinopril	Lisinopril	281	85
Omeprazole	Omeprazole	275	87
Gabapentin	Gabapentin	242	66
Albuterol Sulfate Hfa	Albuterol Sulfate	233	64
Levothyroxine Sodium	Levothyroxine Sodium	224	68
Tramadol Hcl	Tramadol Hcl	219	43
Losartan Potassium	Losartan Potassium	210	69
Alprazolam	Alprazolam	196	30
Hydrochlorothiazide	Hydrochlorothiazide	194	52
Metformin Hcl	Metformin Hcl	177	55
Carvedilol	Carvedilol	167	50
Tamsulosin Hcl	Tamsulosin Hcl	157	54
Metoprolol Succinate	Metoprolol Succinate	155	51
Ozempic	Semaglutide	145	23
Rosuvastatin Calcium	Rosuvastatin Calcium	135	42
Fluticasone Propionate	Fluticasone Propionate	127	48
Jardiance	Empagliflozin	122	30
Pantoprazole Sodium	Pantoprazole Sodium	116	33
Eliquis	Apixaban	114	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	113	18
Trazodone Hcl	Trazodone Hcl	101	30
Fluoxetine Hcl	Fluoxetine Hcl	100	33
Meloxicam	Meloxicam	97	28
Furosemide	Furosemide	84	21
Sertraline Hcl	Sertraline Hcl	84	26
Ventolin Hfa	Albuterol Sulfate	82	19
Metoprolol Tartrate	Metoprolol Tartrate	72	24
Spironolactone	Spironolactone	71	20
Simvastatin	Simvastatin	67	18
Montelukast Sodium	Montelukast Sodium	66	16
Clonazepam	Clonazepam	62	14
Mirtazapine	Mirtazapine	62	19
Finasteride	Finasteride	57	17
Glipizide	Glipizide	54	17
Metformin Hcl Er	Metformin Hcl	54	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	17
Bumetanide	Bumetanide	51	17
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Buspirone Hcl	Buspirone Hcl	50	17
Ropinirole Hcl	Ropinirole Hcl	50	13
Celecoxib	Celecoxib	49	12
Duloxetine Hcl	Duloxetine Hcl	49	14
Mounjaro	Tirzepatide	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	15
Lorazepam	Lorazepam	44	11
Pregabalin	Pregabalin	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	44	13
Allopurinol	Allopurinol	42	15
Famotidine	Famotidine	40	11
Prednisone	Prednisone	39	26
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	14
Acetaminophen-Codeine	Acetaminophen With Codeine	36	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	21
Warfarin Sodium	Warfarin Sodium	33	12
Topiramate	Topiramate	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Naproxen	Naproxen	28	17
Potassium Chloride	Potassium Chloride	28	13
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Tresiba Flextouch U-100	Insulin Degludec	27	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Baclofen	Baclofen	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Imipramine Hcl	Imipramine Hcl	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Diazepam	Diazepam	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Lactulose	Lactulose	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Novolog	Insulin Aspart	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Estradiol	Estradiol	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Droxidopa	Droxidopa	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error